NEWS - FDA approves tramadol extended-release formulation for chronic pain

[Guest guest]

FDA Approves Tramadol Extended-Release Formulation for Chronic Pain

Information from Industry

Find out about a head-to-head comparison of MS treatment options

Dr. Mikol discusses the findings from the multicenter REGARD

study.Click here.

January 6, 2009 — Labopharm announced that the Food and Drug

Administration (FDA) has approved an extended-release once-daily

formulation of tramadol (Ryzolt) for the management of moderate to

moderately severe chronic pain.

The new formulation of tramadol uses the company's proprietary

controlled-release technology (Contramid) for oral administration of

existing solid-dosage medications and is the first approval in the

United States obtained by Labopharm for 1 of these compounds.

***************************************************

Read the full article here:

http://www.medscape.com/viewarticle/586329

Not an MD

[Guest guest]

Thanks for sharing this .

Clicked on the link below but the site said to log in first which I

don't belong to.

Debbie L

>

> FDA Approves Tramadol Extended-Release Formulation for Chronic Pain

>

>

>

> Information from Industry

> Find out about a head-to-head comparison of MS treatment options

> Dr. Mikol discusses the findings from the multicenter REGARD

> study.Click here.

>

>

> January 6, 2009 — Labopharm announced that the Food and Drug

> Administration (FDA) has approved an extended-release once-daily

> formulation of tramadol (Ryzolt) for the management of moderate to

> moderately severe chronic pain.

>

>

> The new formulation of tramadol uses the company's proprietary

> controlled-release technology (Contramid) for oral administration of

> existing solid-dosage medications and is the first approval in the

> United States obtained by Labopharm for 1 of these compounds.

>

> ***************************************************

> Read the full article here:

>

> http://www.medscape.com/viewarticle/586329

>

>

>

> Not an MD

>